The prognostic value of clinical, pathologic, and biologic parameters in ovarian cancer (original) (raw)
Prognostic significance of tumor ploidy in patients with advanced ovarian carcinoma
Soo Khoo
Gynecologic Oncology, 1990
View PDFchevron_right
Tumor ploidy as a major prognostic factor in advanced ovarian cancer
Gert Fleuren
Cancer, 1987
View PDFchevron_right
Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma
Marianne Gunther
Cancer research, 1985
View PDFchevron_right
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
Gunnar Kristensen
International Journal of Gynecological Cancer, 2001
View PDFchevron_right
Ploidy level, histopathological differentiation and response to chemotherapy in serous ovarian cancer
Anders Jakobsen
European Journal of Cancer and Clinical Oncology, 1989
View PDFchevron_right
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer
Gunnar Kristensen
Annals of Oncology, 2003
View PDFchevron_right
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma
Cecilia Molino, G. Amunni
Cancer, 2007
View PDFchevron_right
Prognostic factors in ovarian carcinoma stage III patients. Can biomarkers improve the prediction of short- and long-term survivors?
Morteza Aghmesheh
International Journal of Gynecological Cancer, 2005
View PDFchevron_right
Patterns and Progress in Ovarian Cancer Over 14 Years
Nelson Teng
Obstetrics & Gynecology, 2006
View PDFchevron_right
The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma
Curt Burger
BJOG: An International Journal of Obstetrics & Gynaecology, 2009
View PDFchevron_right
Laboratory predictors of survival in ovarian cancer
Rosekeila Nomelini
Revista da Associação Médica Brasileira
View PDFchevron_right
Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma
Laurentia Gales
Medicina
View PDFchevron_right
Ovarian cancer stages I and II: Predictions and 5-year survival in two decades
Seth Granberg
Gynecologic Oncology, 1989
View PDFchevron_right
Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades
John Malone
American Journal of Obstetrics and Gynecology, 2003
View PDFchevron_right
Evaluation of clinical characteristics linked with the survival of patients with advanced-stage ovarian malignancies
Milan Terzic
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2017
View PDFchevron_right
Prognostic factors in early-stage ovarian cancer
Stefano Calza
Ecancermedicalscience, 2013
View PDFchevron_right
Quantitative Prognostic Features in FIGO I Ovarian Cancer Patients without Postoperative Treatment
Jane Brugghe
Gynecologic Oncology, 1998
View PDFchevron_right
Advanced ovarian cancer correlation of histologic grade with response to therapy and survival
Robert Ozols
Cancer, 1980
View PDFchevron_right
DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy
Anna Tesei
OncoTargets and Therapy
View PDFchevron_right
Assessment of Prognostic Factors in Epithelial Ovarian Cancer-
hilmi kodaz
View PDFchevron_right
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
G. Launoy
Gynecologic oncology, 2017
View PDFchevron_right
Early stage epithelial ovarian cancers: A study of morphologic prognostic factors
Aysen Terzi
Pathology - Research and Practice, 2013
View PDFchevron_right
Prognostic Significance of Residual Disease in Patients with Stage IV Epithelial Ovarian Cancer
Thomas Burke
Gynecologic Oncology, 1997
View PDFchevron_right
Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
William Winter, Michael Sundborg
Journal of Clinical Oncology, 2008
View PDFchevron_right
Clinical Value of Morphometric and DNA Flow Cytometric Variables as Independent Predictors of Survival in Epithelial Ovarian Carcinoma: A 5-year Follow-up Study
Marije van de Water
International Journal of Gynecological Pathology, 2009
View PDFchevron_right
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum
Hedia Belhadj
European journal of obstetrics, gynecology, and reproductive biology, 2015
View PDFchevron_right
Prognostic Factors for Stage I Ovarian Carcinoma
Louis Dainty
International Journal of Gynecological Pathology, 2010
View PDFchevron_right
Aetiology, Epidemiology, Histopathology, Classification, Detailed Evaluation, and Treatment of Ovarian Cancer
Ashish Anjankar
Cureus, 2022
View PDFchevron_right
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma
Juan Manuel Rosa
American Journal of Surgical Pathology, 2019
View PDFchevron_right
Stage IV ovarian cancer: Disease site-specific rationale for postoperative treatment
Karl Podratz
Gynecologic Oncology, 2009
View PDFchevron_right
Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))
Valter Torri
British journal of cancer, 1990
View PDFchevron_right
Ovarian cancer – where are we today?
Bogdan Gaspar
Practica medicală, 2022
View PDFchevron_right